a month ago
JNJ
AnalystsTim AndersonTim Anderson's Stock Forecasts
AnalystsTim Anderson
Sectors:
Industries:
Analyst Ranking
Top 30%
#1468 out of 4995 analysts
Average Return
+8.02%
Win Rate
63%12 out of 19
Risk vs Reward
Poor
Good
Tim Anderson's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Moderna IncMRNA | +34.67% | $41.51 | $27.12 | 2024-12-10 - 2025-08-22 | Sell |
Abbvie IncABBV | +30.45% | $114.68 | $149.60 | 2021-05-03 - 2022-05-03 | Buy |
Gilead Sciences IncGILD | +24.29% | $92.34 | $114.77 | 2024-12-10 - 2025-08-22 | Strong Buy |
Regeneron Pharmaceuticals IncREGN | +24.28% | $778.50 | $589.48 | 2024-12-10 - 2025-08-22 | Sell |
Metsera IncMTSR | +20.93% | $27.33 | $33.05 | 2025-02-25 - 2025-08-22 | Strong Buy |
Tim Anderson Analyst Color
Get additional color on Tim Anderson's coverage of popular stocks
4 months ago
JNJ
6 months ago
GILD
7 months ago
MRK
7 months ago
JNJ
7 months ago
JNJ
8 months ago
PFE
8 months ago
LLY
Tim Anderson's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Pfizer IncPFE | 2 | Hold | $28.00 | +8.19% | Maintains | 18 days ago |
Amgen IncAMGN | 4 | Sell | $261.00 | -11.14% | Maintains | a month ago |
Johnson & JohnsonJNJ | 6 | Hold | $175.00 | -2.39% | Maintains | a month ago |
Regeneron Pharmaceuticals IncREGN | 2 | Sell | $547.00 | -7.21% | Maintains | 4 months ago |
Aardvark Therapeutics IncAARD | 2 | Strong Buy | $26.00 | +166.12% | Maintains | 5 months ago |
Gilead Sciences IncGILD | 3 | Strong Buy | $126.00 | +9.78% | Maintains | 6 months ago |
Abbvie IncABBV | 4 | Hold | $223.00 | +5.89% | Maintains | 6 months ago |
Metsera IncMTSR | 1 | Strong Buy | $38.00 | +14.98% | Initiates Coverage On | 6 months ago |
Moderna IncMRNA | 2 | Sell | $34.00 | +25.37% | Maintains | 6 months ago |
Merck & Co IncMRK | 4 | Strong Buy | $112.00 | +28.19% | Maintains | 7 months ago |
Bristol Myers Squibb CoBMY | 1 | Hold | $63.00 | +31.47% | Reinstates | 8 months ago |
Biogen IncBIIB | 1 | Hold | $178.00 | +27.77% | Reinstates | 8 months ago |
Eli Lilly & CoLLY | 1 | Strong Buy | $997.00 | +40.09% | Reinstates | 8 months ago |
Novartis AgNVS | 1 | Hold | N/A | N/A | Downgrades | 3 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.